Bildkälla: Stockfoto

Corline Biomedical: Making progress - Redeye

Redeye’s early key take-away is that Corline’s improves partner support and advances Renaparin ahead of the European phase 2 trial.

Redeye’s early key take-away is that Corline’s improves partner support and advances Renaparin ahead of the European phase 2 trial.
Börsvärldens nyhetsbrev
ANNONSER